Ginkgo touts gene therapy one-stop shop capabilities following acquisition
Ginkgo acquires StrideBio's adeno-associated virus (AAV) capsid discovery and engineering platform assets and as well as gaining ownership of a preclinical asset.
Archives for April 11, 2023
AnaBios acquires Cell Systems to expand cell portfolio
Cell Systems is a human primary cell and cell culture media company, with the deal allowing AnaBios to expand its existing portfolio.
Caribou gets FDA fast track for allogeneic CAR-T
The clinical stage company announces that its potential treatment for relapsed or refractory multiple myeloma receives nod for speedier review by the FDA.